These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30628649)

  • 1. Study of the cytological features of bone marrow mesenchymal stem cells from patients with neuromyelitis optica.
    Yang C; Yang Y; Ma L; Zhang GX; Shi FD; Yan Y; Chang G
    Int J Mol Med; 2019 Mar; 43(3):1395-1405. PubMed ID: 30628649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
    Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
    Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of the IL7Ra signaling pathway in Neuromyelitis optica.
    Brill L; Lavon I; Vaknin-Dembinsky A
    J Neuroimmunol; 2018 Nov; 324():81-89. PubMed ID: 30248528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells.
    Tamama K; Fan VH; Griffith LG; Blair HC; Wells A
    Stem Cells; 2006 Mar; 24(3):686-95. PubMed ID: 16150920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
    Brück W; Popescu B; Lucchinetti CF; Markovic-Plese S; Gold R; Thal DR; Metz I
    Ann Neurol; 2012 Sep; 72(3):385-94. PubMed ID: 23034911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs).
    Yen ML; Hou CH; Peng KY; Tseng PC; Jiang SS; Shun CT; Chen YC; Kuo ML
    Cell Transplant; 2011; 20(10):1529-45. PubMed ID: 21396155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota regulates bone marrow mesenchymal stem cell lineage differentiation and immunomodulation.
    Xiao E; He L; Wu Q; Li J; He Y; Zhao L; Chen S; An J; Liu Y; Chen C; Zhang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):213. PubMed ID: 28962644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
    Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
    Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bones Morphogenic Protein-4 and retinoic acid combined treatment comparative analysis for in vitro differentiation potential of murine mesenchymal stem cells derived from bone marrow and adipose tissue into germ cells.
    Shirzeyli MH; Khanlarkhani N; Amidi F; Shirzeyli FH; Aval FS; Sobhani A
    Microsc Res Tech; 2017 Nov; 80(11):1151-1160. PubMed ID: 28921810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificities of Children with Multiple Sclerosis and Neuromyelitis Optica.
    Fragoso YD
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):16-20. PubMed ID: 26654228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica.
    Xu J; Zhang F; Gao C; Ma X; Peng X; Kong D; Hao J
    Mol Neurobiol; 2017 Apr; 54(3):2201-2208. PubMed ID: 26941100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica: changing concepts.
    Jacob A; Matiello M; Wingerchuk DM; Lucchinetti CF; Pittock SJ; Weinshenker BG
    J Neuroimmunol; 2007 Jul; 187(1-2):126-38. PubMed ID: 17512987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
    Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
    Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromyelitis optica: a clinical update].
    Chiquete E; Navarro-Bonnet J; Ayala-Armas R; Gutiérrez-Gutiérrez N; Solórzano-Meléndez A; Rodríguez-Tapia D; Gómez-Rincón M; Ruiz-Sandoval JL
    Rev Neurol; 2010 Sep; 51(5):289-94. PubMed ID: 20669128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
    Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
    J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.
    Guo Y; Weigand SD; Popescu BF; Lennon VA; Parisi JE; Pittock SJ; Parks NE; Clardy SL; Howe CL; Lucchinetti CF
    Acta Neuropathol; 2017 Apr; 133(4):597-612. PubMed ID: 28184993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.